IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense®

Core Insights - IceCure Medical Ltd. has received FDA marketing authorization for its ProSense® system, which is designed for the treatment of low-risk breast cancer [1] - The ProSense® system is now included in proposed medical society guidelines for cryoablation in the approved patient population [1] - The first installation of the ProSense® system in Missouri has occurred at Shero Imaging, enabling the clinic to offer breast cancer cryoablation [1]